ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ALLK Company Profile and Key Details

NASDAQ : ALLK

Allakos Inc.

$0.32

0.0007+0.22%

At Close 4:00 PM

64.45

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

ALLK Stock Price Chart

Stock Price Today

Allakos Inc. (ALLK) stock surged +0.22%, trading at $0.32 on NASDAQ, up from the previous close of $0.32. The stock opened at $0.32, fluctuating between $0.32 and $0.32 in the recent session.

Stock Snapshot

0.3185

Prev. Close

0.32

Open

28.79M

Market Cap

90.2M

Number of Shares

0.3181

Day Low

0.322

Day High

-0.25

P/E Ratio

83.97%

Free Float in %

-1.3

EPS (TTM)

1.93

Book Value

-1.34

Cash Flow per Share

1.31M

Volume

Relevant Articles

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 10, 2025	0.32	0.32	0.32	0.32	1.94M
Apr 09, 2025	0.32	0.32	0.31	0.32	1.61M
Apr 08, 2025	0.32	0.32	0.32	0.32	719.54K
Apr 07, 2025	0.32	0.32	0.32	0.32	1.28M
Apr 04, 2025	0.32	0.32	0.31	0.32	2.14M
Apr 03, 2025	0.32	0.32	0.32	0.32	2.93M
Apr 02, 2025	0.31	0.32	0.31	0.32	22.72M
Apr 01, 2025	0.23	0.23	0.22	0.22	434.45K
Mar 31, 2025	0.24	0.24	0.22	0.23	619.89K
Mar 28, 2025	0.24	0.24	0.22	0.23	734.74K
Mar 27, 2025	0.23	0.24	0.23	0.23	312K
Mar 26, 2025	0.23	0.24	0.23	0.23	1.07M
Mar 25, 2025	0.24	0.25	0.24	0.24	944.8K
Mar 24, 2025	0.25	0.25	0.24	0.25	1.64M
Mar 21, 2025	0.25	0.25	0.25	0.25	389.22K
Mar 20, 2025	0.25	0.26	0.25	0.25	480.61K
Mar 19, 2025	0.26	0.26	0.25	0.26	1.25M
Mar 18, 2025	0.25	0.26	0.25	0.26	152.66K
Mar 17, 2025	0.25	0.26	0.25	0.25	451.04K
Mar 14, 2025	0.26	0.26	0.24	0.25	410.7K

Contact Details

Redwood City, CA 94065

United States

Website: https://www.allakos.comContact: 650 597 5002

About Company

Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; a Phase II/III study for eosinophilic esophagitis; and a Phase II clinical study to atopic dermatitis and chronic spontaneous urticaria. It is also developing lirentelimab (AK002) for the treatment of mast cell gastrointestinal disease, chronic urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis; and AK006 to treat allergic and inflammatory diseases. The company was incorporated in 2012 and is headquartered in Redwood City, California.

Frequently Asked Questions

What is the current Allakos Inc. (ALLK) stock price?

Allakos Inc. (NASDAQ: ALLK) stock price is $0.32 in the last trading session. During the trading session, ALLK stock reached the peak price of $0.32 while $0.32 was the lowest point it dropped to. The percentage change in ALLK stock occurred in the recent session was 0.22% while the dollar amount for the price change in ALLK stock was $0.00.

ALLK's industry and sector of operation?

The NASDAQ listed ALLK is part of Biotechnology industry that operates in the broader Healthcare sector. Allakos Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ALLK?

Mr. Scott Hirsch M.B.A.
Chief Operating Officer
Brad Youngblood
Head of Research
Dr. Adam L. Tomasi Ph.D.
Pres
Dr. Robert Alexander Ph.D.
Chief Executive Officer & Director
Dr. Henrik Sandvad Rasmussen
Strategic Advisor
Mr. Baird Radford III
Chief Financial Officer
Dr. Craig Paterson M.D.
Chief Medical Officer
Ms. Mary Cromwell Ph.D.
Chief Technical Officer
Dr. Henrik Sandvad Rasmussen M.D., Ph.D.
Strategic Advisor
Dr. Brad Youngblood Ph.D.
Head of Research & Pre-Clinical Devel.
Mr. Alan Chang
Director of Medical Affairs & Data Analytics

How ALLK did perform over past 52-week?

ALLK's closing price is 45.09% higher than its 52-week low of $0.22 where as its distance from 52-week high of $1.56 is -79.54%.

How many employees does ALLK have?

Number of ALLK employees currently stands at 131.

Link for ALLK official website?

Official Website of ALLK is: https://www.allakos.com

How do I contact ALLK?

ALLK could be contacted at phone 650 597 5002 and can also be accessed through its website. ALLK operates from 975 Island Drive, Redwood City, CA 94065, United States.

How many shares of ALLK are traded daily?

ALLK stock volume for the day was 1.31M shares. The average number of ALLK shares traded daily for last 3 months was 2.85M.

What is the market cap of ALLK currently?

The market value of ALLK currently stands at $28.79M with its latest stock price at $0.32 and 90.2M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	131
Beta	0.71
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology